Condensed pyrimidines
US4495189A · kind A · utility
Assignee
Inventors
Key dates
| Filing date | Apr 2, 1982 |
| Grant date | Jan 22, 1985 |
| Priority date | — |
| Expiry date | Apr 2, 2002 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D471/04
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
New compounds of the following formula are disclosed: PA1 1,6-dimethyl-3-carbamoyl-4-oxo-1,6,7,8-tetrahydro-4H-pyrido(1,2-a)-pyrimidi ne; PA1 1,6-dimethyl-3-(N-tertiary-butyl-carbamoyl)-4-oxo-1,6,7,8-tetrahydro-4H-pyr ido(1,2-a)pyrimidine; PA1 1,6-dimethyl-3-(N-2-phenethyl-carbamoyl)-4-oxo-1,6,7,8-tetrahydro-4H-pyrido (1,2-a)pyrimidine; PA1 1,6-dimethyl-3-[N-(3,3-diphenyl-propyl)-carbamoyl]-4-oxo-1,6,7,8-tetrahydro -4H-pyrido(1,2-a)pyrimidine; PA1 1,6-dimethyl-3-(N-phenyl-carbamoyl)-4-oxo-1,6,7,8-tetrahydro-4H-pyrido(1,2- a)pyrimidine; and PA1 1,6-dimethyl-3-(N-methyl-carbamoyl)-4-oxo-1,6,7,8-tetrahydro-4H-pyrido(1,2- a)pyrimidine, as well as pharmaceutical compositions containing these compounds and a method of inhibiting thrombocyte aggregation in mammals employing a pharmaceutically effective amount of at least one of these compounds.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.